BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15177502)

  • 1. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
    Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
    Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
    Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
    Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct.
    Awadallah NS; Shroyer KR; Langer DA; Torkko KC; Chen YK; Bentz JS; Papkoff J; Liu W; Nash SR; Shah RJ
    Pancreas; 2008 Mar; 36(2):200-6. PubMed ID: 18376314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
    Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J
    J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
    Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
    Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
    Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
    J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis.
    Geers C; Moulin P; Gigot JF; Weynand B; Deprez P; Rahier J; Sempoux C
    Am J Surg Pathol; 2006 Oct; 30(10):1243-9. PubMed ID: 17001154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
    Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
    Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.
    Durkin AJ; Bloomston M; Yeatman TJ; Gilbert-Barness E; Cojita D; Rosemurgy AS; Zervos EE
    J Am Coll Surg; 2004 Nov; 199(5):724-31. PubMed ID: 15501112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
    de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
    Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
    Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
    Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
    Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
    Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
    Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
    Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
    Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.